Seroconversion After Coronavirus Disease 2019 Vaccination
Pathum Sookaromdee, Viroj Wiwanitkit – 6 October 2021
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment
Marina Serper, Sumeet Asrani, Lisa VanWagner, Peter P. Reese, Minjee Kim, Michael S. Wolf – 4 October 2021 – Liver transplantation (LT), the only cure for end‐stage liver disease, is a lifesaving, costly, and limited resource. LT recipients (LTRs) are aging with an increasing burden of medical comorbidities. Patient and graft survival rates exceed 70% at 5 years; however, patient‐centered health outcomes beyond survival have received relatively little attention.
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours
Angus Hann, Hanns Lembach, Anisa Nutu, Hynek Mergental, John L. Isaac, John R. Isaac, Ye H. Oo, Matthew J. Armstrong, Neil Rajoriya, Simon Afford, David Bartlett, Darius F. Mirza, Hermien Hartog, M. Thamara P.R. Perera – 3 October 2021
MicroRNA‐206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c‐Myc mice
Ningning Liu, Clifford J. Steer, Guisheng Song – 3 October 2021
BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial
Eric J. Lawitz, Diane E. Shevell, Giridhar S. Tirucherai, Shuyan Du, Warner Chen, Uma Kavita, Angie Coste, Fred Poordad, Morten Karsdal, Mette Nielsen, Zachary Goodman, Edgar D. Charles – 3 October 2021
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yao Yang, Jinjung Choi, Ying Chen, Pietro Invernizzi, Guoxiang Yang, Weici Zhang, Ti‐hong Shao, Frank Jordan, Natalia S. Nemeria, Ross L. Coppel, William M. Ridgway, Mark Kurth, Aftab A. Ansari, Patrick S.C. Leung, M. Eric Gershwin – 3 October 2021
Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5‐Year Follow‐Up
Morgan Vandermeulen, Maleyko Mohamed‐Wais, Pauline Erpicum, Marie‐Hélène Delbouille, Chantal Lechanteur, Alexandra Briquet, Gianni Maggipinto, François Jouret, Yves Beguin, Olivier Detry – 2 October 2021 – Various properties of mesenchymal stromal cells (MSCs) might be particularly of interest after liver transplantation (LT). In this article, we report the long‐term results of a prospective, controlled, and first‐in‐human phase 1 study evaluating the safety of a single MSC infusion after LT.
Associations Between Alcohol Use and Liver‐Related Outcomes in a Large National Cohort of Patients With Cirrhosis
Meredith M. Pearson, Nicole J. Kim, Kristin Berry, Andrew M. Moon, Feng Su, Philip Vutien, Pamela K. Green, Emily C. Williams, George N. Ioannou – 2 October 2021 – Alcohol use can cause hepatic necroinflammation and worsening portal hypertension in patients with cirrhosis. We aimed to evaluate the associations between degree of alcohol use and clinical liver‐related outcomes according to etiology of cirrhosis. In this retrospective cohort analysis, 44,349 U.S.
Issue Information
30 September 2021
Issue Information
30 September 2021